Compounds > 8-bromo cyclic adenosine monophosphate

8-bromo cyclic adenosine monophosphate and Diabetes Mellitus, Type 1

8-bromo cyclic adenosine monophosphate has been researched along with Diabetes Mellitus, Type 1 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MARBLE, A; STEPHENS, JW1
Liu, XF; Shimoni, Y1
Kurland, IJ; Pei, L; Tontonoz, P; Vaitheesvaran, B; Waki, H; Wilpitz, DC1
Beshay, E; Croze, F; Prud'homme, GJ1

Other Studies

4 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Diabetes Mellitus, Type 1

ArticleYear
Place and value of summer camps in management of juvenile diabetes; observations and a report of activities at a camp for diabetic boys in 1950.
    A.M.A. American journal of diseases of children, 1951, Volume: 82, Issue:3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Disease Management; Humans; Infant

1951
Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Action Potentials; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Enzyme Inhibitors; Female; Genistein; Indoles; Male; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein-Tyrosine Kinases; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Signal Transduction; Tetrahydroisoquinolines; Thionucleotides

2004
NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism.
    Nature medicine, 2006, Volume: 12, Issue:9

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperglycemia; Liver; Male; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; Nuclear Receptor Subfamily 4, Group A, Member 2; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Transcription Factors

2006
The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
    Clinical immunology (Orlando, Fla.), 2001, Volume: 98, Issue:2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Autoimmune Diseases; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 1; Dibutyryl Cyclic GMP; Disease Models, Animal; Drug Evaluation, Preclinical; Enterotoxins; Enzyme Induction; Female; Interferon-gamma; Interleukin-12; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred NOD; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Pentoxifylline; Phosphodiesterase Inhibitors; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rolipram; Tumor Necrosis Factor-alpha

2001